The development of the clinical studies groups (CSG) for diabetes aims to bring the principal researchers in the most significant areas of diabetes together in order to improve current care.
Development of a research roadmap
Other health conditions have had notable, enduring effects on the quality of research implementation through CSGs. Diabetes UK is hoping for the same result in this case. Both healthy and patient volunteers are needed. Through medical studies that pay, priority areas can be identified and a roadmap for new research can be established. Identifying pivotal clinical studies will help improve care, and a CSG network will clear the way for pooled clinical research.
Achieving the world’s first collaboration of its type
Research director at Diabetes UK, Dr Elizabeth Robertson, believes that the joint efforts of diabetes sufferers and treatment professionals will cover the holes in existing research. She realises that this is an extremely important moment in diabetes research and a first in the world for the diabetes community. Leaders in the field of diabetes treatment will have the chance to collaborate, expedite research and ultimately improve the lives of sufferers.
Lis Warren wants treatment facilities to encourage their patients to take part in these trials. She is a type 1 diabetic and is excited about the prospect of playing a part in finding better management solutions for treatment. She is concerned that people are not reminded often enough that these trials exist. Clinical research organisations like http://www.trials4us.co.uk/ will play a major role in studies of this kind. Individuals who are interested in taking part can find relevant information on http://www.nhs.uk/conditions/Clinical-trials/Pages/Introduction.aspx. Socially, it is an opportunity to receive support from others in the same position and receive clinical support. It also enhances one’s desire to take better care of the condition.
How it will be set up
Experts in their specific fields have been chosen to chair each section. These sections will include causes, prevention, therapies and targets for both type 1 and 2 diabetes, acute care, glycemic control, microvascular complications, and children’s diabetes and endocrinology. Over time, the CSGs are most likely to adapt to the evolving nature of diabetes research. The initial aim, however, is to establish which CSGs need to be targeted in order to advance the care of the multitude of people who are currently living with diabetes.